Skip to main content
ALGORAE PHARMACEUTICALS LIMITED logo

ALGORAE PHARMACEUTICALS LIMITED — Investor Relations & Filings

Ticker · 1AI ISIN · AU0000296022 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,159 across all filing types
Latest filing 2011-04-17 Share Issue/Capital Cha…
Country AU Australia
Listing ASX 1AI

About ALGORAE PHARMACEUTICALS LIMITED

https://algoraepharma.com/

Algorae Pharmaceuticals Limited is a biopharmaceutical company focused on the discovery and development of novel therapeutic solutions for complex medical conditions. The company leverages its proprietary artificial intelligence platform, AlgoraeOS, to streamline the drug discovery process and identify synergistic drug combinations. Its research pipeline primarily targets neurodegenerative diseases and other areas of high unmet clinical need. Key development programs include AI-116, a combination therapy aimed at treating dementia and Alzheimer's disease. By integrating advanced computational modeling with traditional pharmacological research, the company seeks to accelerate the transition of candidates from preclinical stages to clinical trials, optimizing therapeutic efficacy and safety profiles.

Recent filings

Filing Released Lang Actions
Cleansing Statement 1 page 25.6KB
Share Issue/Capital Change Classification · 95% confidence The document is a notice under Section 708A(5)(e) of the Corporations Act regarding the issuance of shares without disclosure under Part 6D.2 of the Corporations Act. It is a formal announcement about a share issue related to compliance with regulatory provisions. The document is short (1186 characters) and focuses on the issuance of shares and legal compliance, not a full financial report or detailed analysis. This fits the category of Share Issue/Capital Change announcements rather than a full report or other filing types.
2011-04-17 English
LCT and Otsuka of Japan Share Common DIABECELL Vision 3 pages 203.1KB
Capital/Financing Update Classification · 95% confidence The document is a company announcement from Living Cell Technologies Limited regarding a capital investment by Otsuka Pharmaceutical Factory, Inc. It details a share placement raising AUD $3 million, the terms of the investment, and the strategic collaboration for product development and commercialization. The content focuses on fundraising, share issuance, and partnership agreements rather than financial results, management changes, or regulatory filings. The document length is 9223 characters, which is substantial but the content is clearly about a financing update and capital structure change. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2011-04-11 English
Initial Director`s Interest Notice 2 pages 28.2KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including options held and their terms. The document is a formal notification of a director's personal share transactions or interests, which aligns with the definition of Director's Dealing filings. The document length is short and focused solely on director interests, with no financial results or management discussion. Therefore, it fits the category of Director's Dealing (DIRS).
2011-04-03 English
LCT Strengthens Board of Directors with New Appointment 2 pages 37.5KB
Board/Management Information Classification · 100% confidence The document is a company announcement from Living Cell Technologies Limited about the appointment of a new member to its board of directors. It details the background and qualifications of the new appointee, Robert M Willcocks, and includes quotes from the company's chairman. There is no financial data, no discussion of financial results, no regulatory filings, or other report types. The content clearly fits the category of announcements related to changes in the company's board of directors or senior management. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is sufficient and the content is focused solely on management changes, confirming the classification with high confidence.
2011-03-28 English
Final Director`s Interest Notice 2 pages 36.0KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Z Final Director’s Interest Notice' and references ASX listing rule 3.19A.3 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including unlisted options held by related parties, and the date the director ceased to be a director. This is a report of personal share transactions or holdings by a company director, which fits the definition of Director's Dealing filings. The document length is short and focused solely on director interests, with no financial statements or other report content. Therefore, the correct classification is Director's Dealing (DIRS).
2011-03-14 English
Director resignation 2 pages 35.2KB
Board/Management Information Classification · 100% confidence The document is a company announcement from Living Cell Technologies Limited regarding the resignation of a director, Mr. Robert Finder. It is dated 14 March 2011 and details the director's resignation, his appointment date, and the company's plans to find a replacement. There is no financial data, no mention of financial results, no regulatory filings or certifications, and no reference to any report publication. The content is focused solely on a change in the company's board of directors. Therefore, this document fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2011-03-13 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.